Abstract: A system and method is provided for converting an input signal from a sequence of rectangular coordinate pairs to a sequence of polar coordinate pairs. The input signal includes a sequence of input vectors each including a pair of rectangular coordinates. A plurality of N input registers is configured to store an input vector of the input signal. The system includes a plurality of N CORDIC algorithm instances, each in communication with a corresponding one of the N input registers. Each CORDIC algorithm instance is configured to receive the input vector stored in the corresponding input register and to convert the received input vector to a corresponding output vector including a pair of polar coordinates. A recombiner is configured to receive the N output vectors and to recombine at least the N output vectors in sequence to form an output signal.

Abstract: Compounds useful for lowering beta amyloid levels are provided. The compounds have the structure of formula Ia: wherein, R1 is lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, or SO2R5; R5 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, or substituted alkyl; R2 is lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, or cycloalkyl; R3 is hydrogen, lower alkyl, or substituted lower alkyl; R4 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, thiophene, or substituted thiophene; R6 is hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, or substituted cycloalkyl; W, X and Y are independently CR7 or N; and R7 is hydrogen, halogen, lower alkyl, or substituted lower alkyl.

Abstract: Compounds of Formula I, wherein R1-R8 are defined herein are provided, together with pharmaceutically acceptable salts, hydrates, metabolites, and/or prodrugs thereof. Uses of these compounds for inhibiting beta amyloid production and for the prevention and treatment of Alzheimer's Disease and Down's syndrome are also described.

Abstract: A flexible energy storage device comprising a flexible housing; an electrolyte contained within the housing; an anode and cathode comprise a current collector and anode/cathode material supported on the current collector. The current collector comprising a fabric substrate (101) and an electron-conductive material (102). The electron conductive material contains voids to enable penetration of the current collector by the electrolyte.

Abstract: Compounds of Formula (I), are provided where T is CHO, COR8, or C(OH)R1R2; R1 and R2 are hydrogen, optionally substituted lower alkyl, CF3, optionally substituted alkenyl, or optionally substituted alkynyl; R3 is hydrogen or optionally substituted lower alkyl; R4 is (CF3)nalkyl, (CF3)n(substitutedalkyl), (CF3)nalkylphenyl, (CF3)nalkyl(substitutedphenyl), or (F)ncycloalkyl; n=1-3; R5 is hydrogen, halogen, CF3, diene fused to Y when Y=C, or substituted diene fused to Y when Y=C; W, Y and Z are C, CR6 or N where at least one of W, Y or Z are C; R6 is hydrogen, halogen, or optionally substituted lower alkyl; X is O, S, SO2, or NR7; R7 is hydrogen, optionally substituted lower alkyl, optionally substituted benzyl, or optionally substituted phenyl; and R8 is lower alkyl, CF3, or optionally substituted phenyl. Methods of preparing and using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer's Disease and Down's syndrome are also described.

Abstract: Compounds of Formula (I), are provided where T is CHO, COR8, or C(OH)R1R2; R1 and R2 are hydrogen, optionally substituted lower alkyl, CF3, optionally substituted alkenyl, or optionally substituted alkynyl; R3 is hydrogen or optionally substituted lower alkyl; R4 is (CF3)nalkyl, (CF3)n(substituted alkyl), (CF3)nalkylphenyl, (CF3)nalkyl(substituted phenyl), or (F)ncycloalkyl; n=1-3; R5 is hydrogen, halogen, CF3, diene fused to Y when Y?C, or substituted diene fused to Y when Y?C; W, Y and Z are C, CR6 or N where at least one of W, Y or Z are C; R6 is hydrogen, halogen, or optionally substituted lower alkyl; X is O, S, SO2, or NR7; R7 is hydrogen, optionally substituted lower alkyl, optionally substituted benzyl, or optionally substituted phenyl; and R8 is lower alkyl, CF3, or optionally substituted phenyl. Methods of preparing and using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer's Disease and Down's syndrome are also described.

Abstract: An air duct support for supporting air ducts and similar pipes without constricting airflow through the pipes. The support has an arcuate main body portion for receiving a portion of the conduit therein and an upright support attached to a bottom of the top portion and supporting the conduit at an elevated position in relation to a base surface. The support member may be a unitary body or telescopically extendable member. The top portion rotates 360 degrees in relation to the support member to accommodate any direction of extension of the conduit. A collar plate or a flexible strap may be positioned about an unsecured portion of the conduit to prevent displacement of the conduit in relation to the main body.

Abstract: Pyrrolidinium-based room temperature ionic liquids, and phosphorus and arsenic analogues, are used as electrolytes in energy storage devices including secondary lithium batteries, supercapacitors and asymmetric battery-supercapacitors. The electrolytes preferably contain lithium ions as the charge-carrying species. The electrolytes are in a liquid state at the operating temperature.

Abstract: A pressure transducer for high-pressure measurements comprising a housing and a piezoelectric resonator located in the housing, wherein the resonator comprises double rotation cut piezoelectric material configured or designed for vibrating in the fundamental tone of dual modes of the fast and slow thickness-shear vibrations.

Abstract: Compounds useful for lowering beta amyloid levels are provided. The compounds have the structure of formula Ia: wherein, R1 is lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, or SO2R5; R5 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, or substituted alkyl; R2 is lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, or cycloalkyl; R3 is hydrogen, lower alkyl, or substituted lower alkyl; R4 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, thiophene, or substituted thiophene; R6 is hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, or substituted cycloalkyl; W, X and Y are independently CR7 or N; and R7 is hydrogen, halogen, lower alkyl, or substituted lower alkyl.

Abstract: Compounds useful for lowering beta amyloid levels are provided. The compounds have the structure of formula Ia: wherein, R1 is lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, or SO2R5; R5 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, or substituted alkyl; R2 is lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, or cycloalkyl; R3 is hydrogen, lower alkyl, or substituted lower alkyl; R4 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, thiophene, or substituted thiophene; R6 is hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, or substituted cycloalkyl; W, X and Y are independently CR7 or N; and R7 is hydrogen, halogen, lower alkyl, or substituted lower alkyl.

Abstract: In one embodiment of the present invention, a memory system is disclosed to include at least one initiator, a SATA device, and an improved bridge device configured to facilitate communication between the at least one initiator and the SATA device and having at least one input port and operative to receive information through the input port(s) from the initiators, the improved bridge device for processing a notification event wherein notification is sent to the at least one initiators during a notification event, and for performing an action, based on a an event, thereby facilitating ease of communication between the initiator and the SATA device.

Abstract: Compounds of Formula (I), are provided where T is CHO, CON, or C(OH)R1R2; R1 and R2 are hydrogen, optionally substituted lower alkyl, CF3, optionally substituted alkenyl, or optionally substituted alkynyl; R3 is hydrogen or optionally substituted lower alkyl; R4 is (CF3)nalkyl, (CF3)n(substitutedalkyl), (CF3)nalkylphenyl, (CF3)nalkyl(substitutedphenyl), or (F)ncycloalkyl; n=1-3; R5 is hydrogen, halogen, CF3, diene fused to Y when Y?C, or substituted diene fused to Y when Y?C; W, Y and Z are C, CR6 or N where at least one of W, Y or Z are C; R6 is hydrogen, halogen, or optionally substituted lower alkyl; X is O, S, SO2, or NR7; R7 is hydrogen, optionally substituted lower alkyl, optionally substituted benzyl, or optionally substituted phenyl; and R8 is lower alkyl, CF3, or optionally substituted phenyl. Methods of preparing and using these compounds for inhibiting beta amyloid production and for treatment of Alzheimer's Disease and Down's syndrome are also described.

Abstract: A system, method and computer program product are disclosed for normalizing data in a supply chain management framework. A plurality of data types are defined with each data type including parameters. Data is received utilizing a network from a plurality of point of sale outlets of a supply chain that relates to an amount of goods sold by the point of sale outlets. A format of the data is verified against the parameters of the defined data types and any discrepancies between the format of the data and the parameters of the defined data types are corrected for facilitating an analysis of the data.

Abstract: Compounds of Formula I, wherein R1–R8 are defined herein are provided, together with pharmaceutically acceptable salts, hydrates, metabolites, and/or prodrugs thereof. Uses of these compounds for inhibiting beta amyloid production and for the prevention and treatment of Alzheimer's Disease and Down's syndrome are described.

Abstract: The present invention provides non-destructive computed tomography (CT) methods of testing downhole equipment. The non-destructive CT methods enable both extrinsic and intrinsic testing to ensure the quality of downhole components in elements such as downhole packers.

Abstract: A system, method and computer program product are disclosed for cost reporting using a network-based supply chain management framework. Data is received utilizing a network. This data relates to goods required by a plurality of stores including a product identifier parameter, and a first cost parameter. A second cost parameter associated with a franchise mark-up is also received so that a total cost can be calculated based on the first cost parameter and the second cost parameter. The total cost is displayed utilizing the network with TCP/IP protocol.

Abstract: A system, method and computer program product are disclosed for forecasting the sale of goods. Data is received utilizing a network from a plurality of point of sale outlets of a supply chain where the data relates to an amount of goods sold by the point of sale outlets. The data is checked for errors. Each detected error is identified as either a point of sale set-up error, a point of sale entry error, a back office error, a polling error, or a menu item mapping error so that the data can be corrected using the identification.

Abstract: A tag and method of making it. The tag includes a first adhesive layer provided in a first predetermined pattern between a surface of a first substrate and a first conductive foil. The first pattern corresponds to a pattern for a first conductive trace, e.g., a portion of a resonant circuit. The first conductive foil is laminated, e.g., adhesively secured, to the surface of the first substrate to form a first conductive layer. A first portion of that layer is shaped, e.g., die-cut, to generally correspond to the first pattern. A second portion of the first conductive layer not corresponding to the first portion is removed, to establish the first conductive trace, with the adhesive layer confined within the boundaries of the first conductive trace. Another conductive trace is secured to the first conductive trace, with a dielectric therebetween, to form a resonant circuit.

Abstract: A system, method and computer program product are disclosed for order confirmation in a supply chain management framework. A network is utilized to collect from a plurality of stores of a supply chain data relating to the sale of goods by the stores. Access is allowed to the data utilizing a network-based interface. Electronic order forms are generated based on the data for ordering goods from a plurality of distributors of the supply chain. These electronic order forms request a confirmation of the receipt of the electronic order forms. A determination is made as to whether the confirmation of the receipt of the electronic order forms is received from the distributors. If it is determined that the confirmation of the receipt of the electronic order forms was not from the distributors, then an alert is generated.